{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-025731","form_type":"8-K","ticker":"AFJK","cik":"0001979005","company_name":"Aimei Health Technology Co., Ltd.","filed_at":"2025-12-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:41.199427+00:00","generated_at":"2026-05-16T15:47:50.929733+00:00","sec_items":["1.01","3.03","5.07","5.03","8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Aimei Health shareholders approve extension; 3.94M shares redeemed for ~$44.8M, trust drops to $0.7M","bullets":["Shareholders approved extending business combination deadline from Dec 6, 2025 to Dec 6, 2026.","Trust agreement amended: monthly extension deposit reduced to lesser of $80k or $0.033 per share.","Holders of 3,942,661 public shares redeemed at ~$11.37/share, total ~$44.8M.","Post-redemption, trust account balance ~$0.7M; outstanding shares drop to 2,179,072.","MaloneBailey LLP appointed as independent auditor for FY2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-025731","json":"https://secwatch.observer/filing/0001493152-25-025731.json","markdown":"https://secwatch.observer/filing/0001493152-25-025731.md","text":"https://secwatch.observer/filing/0001493152-25-025731.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1979005/000149315225025731/0001493152-25-025731-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1979005/000149315225025731/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T15:47:50.929733+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2c5d463f1b41b229ea7d15418d52d0e2f71e81e7","claim":"Aimei Health Technology Co., Ltd.: Amended Article 35.2 of the Articles of Association to extend the business combination deadline from 24 to 36 months after the IPO, i.e., to December 6, 2026 (effective 2025-11-26).","evidence_excerpt":"Article 35.2 of the Amended and Restated Articles of Association of the Company, as in effect immediately prior to the Extraordinary General Meeting, was amended and restated to essentially extend the date by which the Company has to consummate a business combination from 24 months from the date of the Company’s initial public offering (namely, December 6, 2025) to 36 months from the date of the Company’s initial public offering (namely, December 6, 2026).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1979005/000149315225025731/0001493152-25-025731-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-11-26"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}